Zoono Group (ZNO.AX) Stock Price

Zoono Group Price

ASX·CLOSED
0.06NZD+0.0012 (+2.06 %)
Market closed

Over the last 19 years Zoono Group grew revenue by 3.8% annually, reaching 1.29 M NZD. Earnings per share have declined at 29.9% per year over the last 11 years. For Zoono Group, the net margin of -303.4% is down versus 17.4% a few years ago. At today's price the dividend yield works out to roughly 51.25%. The payout ratio is around 36% of earnings. The stock trades about 150% above its 52-week low.

Zoono Group stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Zoono Group over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Zoono Group stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Zoono Group's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Zoono Group Stock Price History
DateZoono Group Price
8/4/20260.06 NZD
8/3/20260.06 NZD
7/31/20260.06 NZD
7/30/20260.06 NZD
7/29/20260.07 NZD
7/28/20260.07 NZD
7/27/20260.07 NZD
7/24/20260.06 NZD
7/23/20260.06 NZD
7/22/20260.07 NZD
7/21/20260.07 NZD
7/20/20260.07 NZD
7/17/20260.06 NZD
7/16/20260.07 NZD
7/15/20260.07 NZD
7/14/20260.07 NZD
7/13/20260.07 NZD
7/10/20260.07 NZD
7/9/20260.07 NZD
7/8/20260.07 NZD
7/7/20260.07 NZD
7/6/20260.07 NZD
7/3/20260.07 NZD
7/2/20260.07 NZD
7/1/20260.07 NZD
6/30/20260.07 NZD
6/29/20260.06 NZD
6/26/20260.06 NZD
6/25/20260.06 NZD
6/24/20260.07 NZD
6/23/20260.06 NZD
6/22/20260.07 NZD
6/19/20260.07 NZD
6/18/20260.08 NZD
6/17/20260.08 NZD
6/16/20260.08 NZD
6/15/20260.08 NZD
6/12/20260.08 NZD
6/11/20260.08 NZD
6/10/20260.09 NZD
6/9/20260.08 NZD
6/5/20260.09 NZD
6/4/20260.08 NZD
6/3/20260.08 NZD
6/2/20260.09 NZD
6/1/20260.09 NZD
5/29/20260.09 NZD
5/28/20260.08 NZD
5/27/20260.08 NZD
5/26/20260.08 NZD
5/25/20260.08 NZD
5/22/20260.09 NZD
5/21/20260.09 NZD
5/20/20260.09 NZD
5/19/20260.09 NZD
5/18/20260.08 NZD
5/15/20260.08 NZD
5/14/20260.08 NZD
5/13/20260.08 NZD
5/12/20260.08 NZD
5/11/20260.08 NZD
5/8/20260.08 NZD
5/7/20260.08 NZD
5/6/20260.08 NZD
5/5/20260.08 NZD
5/4/20260.08 NZD
5/1/20260.08 NZD
4/30/20260.08 NZD
4/29/20260.08 NZD
4/28/20260.08 NZD
4/27/20260.08 NZD
4/24/20260.08 NZD
4/23/20260.09 NZD
4/22/20260.09 NZD
4/21/20260.09 NZD
4/20/20260.09 NZD
4/17/20260.09 NZD
4/16/20260.10 NZD
4/15/20260.09 NZD
4/14/20260.09 NZD
4/13/20260.10 NZD
4/10/20260.08 NZD
4/9/20260.08 NZD
4/8/20260.07 NZD
4/7/20260.07 NZD
4/2/20260.08 NZD
4/1/20260.07 NZD
3/31/20260.07 NZD
3/30/20260.08 NZD
3/27/20260.06 NZD
3/26/20260.06 NZD
3/25/20260.06 NZD
3/24/20260.07 NZD
3/23/20260.06 NZD
3/20/20260.06 NZD
3/19/20260.06 NZD
3/18/20260.07 NZD
3/17/20260.07 NZD
3/16/20260.07 NZD
3/13/20260.06 NZD
3/12/20260.07 NZD
3/11/20260.07 NZD
3/10/20260.07 NZD
3/9/20260.07 NZD
3/6/20260.07 NZD
3/5/20260.07 NZD
3/4/20260.06 NZD
3/3/20260.07 NZD
3/2/20260.07 NZD
2/27/20260.07 NZD
2/26/20260.08 NZD
2/25/20260.07 NZD
2/24/20260.06 NZD
2/23/20260.08 NZD
2/20/20260.08 NZD
2/19/20260.08 NZD
2/18/20260.08 NZD
2/17/20260.08 NZD
2/16/20260.08 NZD
2/13/20260.09 NZD
2/12/20260.08 NZD
2/11/20260.08 NZD
2/10/20260.08 NZD
2/9/20260.09 NZD
2/6/20260.09 NZD
2/5/20260.09 NZD
2/4/20260.09 NZD
2/3/20260.09 NZD
2/2/20260.09 NZD
1/30/20260.09 NZD
1/29/20260.09 NZD
1/28/20260.10 NZD
1/27/20260.09 NZD
1/23/20260.09 NZD
1/22/20260.09 NZD
1/21/20260.09 NZD
1/20/20260.09 NZD
1/19/20260.09 NZD
1/16/20260.09 NZD
1/15/20260.09 NZD
1/14/20260.09 NZD
1/13/20260.09 NZD
1/12/20260.08 NZD
1/9/20260.08 NZD
1/8/20260.09 NZD
1/7/20260.08 NZD
1/6/20260.09 NZD
1/5/20260.09 NZD
1/2/20260.09 NZD
12/31/20250.10 NZD
12/30/20250.09 NZD
12/29/20250.09 NZD
12/24/20250.09 NZD
12/23/20250.10 NZD
12/22/20250.10 NZD
12/19/20250.10 NZD
12/18/20250.10 NZD
12/17/20250.10 NZD
12/16/20250.10 NZD
12/15/20250.10 NZD
12/12/20250.10 NZD
12/11/20250.10 NZD
12/10/20250.10 NZD
12/9/20250.10 NZD
12/8/20250.10 NZD
12/5/20250.10 NZD
12/4/20250.10 NZD
12/3/20250.10 NZD
12/2/20250.09 NZD
12/1/20250.08 NZD
11/28/20250.09 NZD
11/27/20250.09 NZD
11/26/20250.09 NZD
11/25/20250.09 NZD
11/24/20250.09 NZD
11/21/20250.09 NZD
11/20/20250.09 NZD
11/19/20250.08 NZD
11/18/20250.08 NZD
11/17/20250.10 NZD
11/14/20250.11 NZD
11/13/20250.11 NZD
11/12/20250.11 NZD
11/11/20250.07 NZD
11/10/20250.06 NZD
11/7/20250.05 NZD
11/6/20250.05 NZD
11/5/20250.03 NZD
11/4/20250.03 NZD
11/3/20250.04 NZD
10/31/20250.03 NZD
10/30/20250.03 NZD
10/29/20250.03 NZD
10/28/20250.04 NZD
10/27/20250.04 NZD
10/24/20250.03 NZD
10/23/20250.03 NZD
10/22/20250.03 NZD
10/21/20250.03 NZD
10/20/20250.03 NZD
10/17/20250.04 NZD
10/16/20250.02 NZD
10/15/20250.03 NZD
10/14/20250.03 NZD
10/13/20250.03 NZD
10/10/20250.02 NZD
10/9/20250.02 NZD
10/8/20250.02 NZD
10/7/20250.03 NZD
10/6/20250.03 NZD
10/3/20250.02 NZD
10/2/20250.02 NZD
10/1/20250.03 NZD
9/30/20250.03 NZD
9/29/20250.02 NZD
9/26/20250.02 NZD
9/25/20250.02 NZD
9/24/20250.03 NZD
9/23/20250.02 NZD
9/22/20250.02 NZD
9/19/20250.02 NZD
9/18/20250.02 NZD
9/17/20250.02 NZD
9/16/20250.02 NZD
9/15/20250.02 NZD
9/12/20250.03 NZD
9/11/20250.02 NZD
9/10/20250.02 NZD
9/9/20250.02 NZD
9/8/20250.02 NZD
9/5/20250.02 NZD
9/4/20250.02 NZD
9/3/20250.02 NZD
9/2/20250.02 NZD
9/1/20250.02 NZD
8/29/20250.02 NZD
8/28/20250.02 NZD
8/27/20250.03 NZD
8/26/20250.02 NZD
8/25/20250.03 NZD
8/22/20250.03 NZD
8/21/20250.03 NZD
8/20/20250.03 NZD
8/19/20250.03 NZD
8/18/20250.02 NZD
8/15/20250.03 NZD
8/14/20250.02 NZD
8/13/20250.03 NZD
8/12/20250.02 NZD
8/11/20250.03 NZD
8/8/20250.03 NZD
8/7/20250.02 NZD
8/6/20250.02 NZD
Access this data via the Eulerpool API
Get Free API Key

Zoono Group Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
2.43 M NZD
191,300.00 NZD
79,700.00 NZD
Jan 1, 2019
1.78 M NZD
-2.31 M NZD
-2.42 M NZD
Jan 1, 2020
38.38 M NZD
20.67 M NZD
16.66 M NZD
Jan 1, 2021
27.15 M NZD
6.07 M NZD
4.73 M NZD
Jan 1, 2022
9.02 M NZD
-6.15 M NZD
-11.39 M NZD
Jan 1, 2023
3.34 M NZD
-578,900.00 NZD
-350,400.00 NZD
Jan 1, 2024
1.05 M NZD
-8.89 M NZD
-9.09 M NZD
Jan 1, 2025
1.29 M NZD
-3.82 M NZD
-3.93 M NZD

Zoono Group Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 5, 2026, 9:53 PM
 
REVENUEM NZD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM NZD
EBITM NZD
EBIT MARGIN%
NET INCOMEM NZD
NET INCOME GROWTH%
DIV.NZD
SHARESM
2010201120122013201420152016201720182019202020212022202320242025
2.001.00––––––2.001.0038.0027.009.003.001.001.00
–-50.00–––––––-50.003,700.00-28.95-66.67-66.67-66.67–
50.00100.00––––––50.00100.0073.6859.2655.5633.33100.00100.00
1.001.001.001.001.001.001.001.001.001.0028.0016.005.001.001.001.00
1.00–-3.00-2.00–-4.00–-2.00–-2.0020.006.00-6.00–-8.00-3.00
50.00––––––––-200.0052.6322.22-66.67–-800.00-300.00
1.00–-4.00-2.00-1.00-4.00–-4.00–-2.0016.004.00-11.00–-9.00-3.00
-200.00––-50.00-50.00300.00––––-900.00-75.00-375.00––-66.67
––––––––––0.030.03––––
1.641.471.712.322.773.1211.3633.13163.01163.10166.30218.96219.28221.53219.37359.03
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Zoono Group generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Zoono Group retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Zoono Group's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Zoono Group has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Zoono Group's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Zoono Group stock margins

The Zoono Group margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Zoono Group. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Zoono Group.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
69.77 %
7.87 %
3.28 %
Jan 1, 2019
45.95 %
-130.21 %
-136.11 %
Jan 1, 2020
73.96 %
53.86 %
43.41 %
Jan 1, 2021
59.37 %
22.36 %
17.43 %
Jan 1, 2022
56.16 %
-68.13 %
-126.32 %
Jan 1, 2023
51.33 %
-17.32 %
-10.49 %
Jan 1, 2024
26.48 %
-843.82 %
-862.20 %
Jan 1, 2025
38.76 %
-295.15 %
-303.41 %

Zoono Group Stock Revenue, EBIT, Earnings per Share

The Zoono Group earnings per share therefore indicates how much revenue Zoono Group has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2018
0.01 NZD
0.00 NZD
0.00 NZD
Jan 1, 2019
0.01 NZD
-0.01 NZD
-0.01 NZD
Jan 1, 2020
0.23 NZD
0.12 NZD
0.10 NZD
Jan 1, 2021
0.12 NZD
0.03 NZD
0.02 NZD
Jan 1, 2022
0.04 NZD
-0.03 NZD
-0.05 NZD
Jan 1, 2023
0.02 NZD
-0.00 NZD
-0.00 NZD
Jan 1, 2024
0.00 NZD
-0.04 NZD
-0.04 NZD
Jan 1, 2025
0.00 NZD
-0.01 NZD
-0.01 NZD

Zoono Group business model & stock analysis

The Zoono Group Ltd is a globally operating company that develops and distributes antimicrobial solutions. The company was founded in New Zealand in 2009 and now has branches and distribution partners in Australia, USA, Canada, Europe, Asia, and South Africa. The business model of Zoono is based on the development and marketing of antimicrobial solutions for use in various industries, such as healthcare, food industry, animal husbandry, and public buildings. The goal of Zoono is to provide a safe and effective alternative to conventional cleaning and disinfection methods. Zoono's products contain special molecules that adhere to surfaces and form a barrier against bacteria, viruses, fungi, and algae. Some of Zoono's products include hand disinfectants, surface disinfectants, air purifiers, and pet care products. The company places a strong emphasis on ensuring that these products are non-toxic, biodegradable, and environmentally friendly. Zoono's solutions have already proven themselves in various industries. For example, they are successfully used in the food industry to prevent the growth of bacteria and mold. The products are also used in healthcare settings because of their long-lasting effectiveness, reducing the risk of infections. In addition to antimicrobial solutions, Zoono also offers consulting services. The company develops individual solutions for customers and adapts the products to meet specific requirements and needs. Thanks to the high effectiveness of their products, extensive network of partners and customers, and constant innovation of new solutions, Zoono has established itself as a successful and forward-thinking company in the industry. In conclusion, the Zoono Group Ltd is an innovative and internationally operating company specializing in the development and marketing of antimicrobial solutions. Their business model is based on the development of safe and effective alternatives to conventional cleaning and disinfection methods. Thanks to the high effectiveness of their products and extensive network of partners and customers, Zoono has established itself as a leading provider in the industry.

Zoono Group SWOT Analysis

Strengths

Zoono Group Ltd has a strong intellectual property portfolio, with multiple patents and trademarks, providing a competitive advantage in the market. This robust IP protection allows the company to maintain exclusivity over its unique products.

The company has a diverse and innovative product range, offering a wide variety of antimicrobial solutions that cater to different industries and applications. This versatility enables Zoono Group Ltd to effectively target multiple market segments and meet various customer needs.

Weaknesses

Zoono Group Ltd is relatively smaller in size compared to some of its competitors, which limits its financial resources and market reach. This can pose challenges in terms of expanding operations, conducting extensive research and development, and penetrating new markets.

The company heavily relies on third-party distributors and resellers to sell its products, which can result in reduced control over the sales process and potential inconsistencies in brand representation. This dependency exposes Zoono Group Ltd to risks associated with the performance and reliability of its distribution channels.

Opportunities

Growing global concern over hygiene and infectious diseases presents a significant opportunity for Zoono Group Ltd to capitalize on its antimicrobial solutions. The company can leverage this increasing demand to expand its customer base and penetrate new industries, such as healthcare, transportation, hospitality, and food processing.

Incorporating its antimicrobial technology into various consumer products, such as personal care items, clothing, and household goods, can open up new revenue streams for Zoono Group Ltd. By partnering with established brands, the company can enhance its market visibility and boost product adoption.

Threats

Intense competition within the antimicrobial industry poses a threat to Zoono Group Ltd. Other companies, including both large multinational corporations and smaller startups, are continuously developing and marketing their own antimicrobial solutions, potentially eroding Zoono's market share.

Regulatory compliance and approvals can present challenges for Zoono Group Ltd, as antimicrobial products are subject to stringent testing and certification processes. Delays or failures in obtaining necessary approvals may hinder the company's ability to launch new products or enter specific markets.

Zoono Group Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Zoono Group historical P/E ratio, EBIT multiple, and P/S ratio

Zoono Group annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Zoono Group shares outstanding

The number of shares of Zoono Group was 359.03 M in 2025. This indicates how many shares Zoono Group is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2018
163.01 M Stocks
Jan 1, 2019
163.10 M Stocks
Jan 1, 2020
166.30 M Stocks
Jan 1, 2021
218.96 M Stocks
Jan 1, 2022
219.28 M Stocks
Jan 1, 2023
221.53 M Stocks
Jan 1, 2024
219.37 M Stocks
Jan 1, 2025
359.03 M Stocks

Zoono Group stock splits

In Zoono Group's history, there have been no stock splits.

Zoono Group Dividend History

2 years of dividend payments

YearAnnual DividendYoY ChangePayments
20210.03NZD 0.0%—
20200.03NZD—1×

Zoono Group dividend payout ratio

In 2025, Zoono Group had a payout ratio of 35.70%. The payout ratio indicates the percentage of the company's profits that Zoono Group distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2018
35.70 %
Jan 1, 2019
35.70 %
Jan 1, 2020
35.70 %
Jan 1, 2021
35.70 %
Jan 1, 2022
35.70 %
Jan 1, 2023
35.70 %
Jan 1, 2024
35.70 %
Jan 1, 2025
35.70 %
Price targets and forecasts for Zoono Group are not yet available.

Zoono Group shareholder structure

% Name
0.55874%
Sterling Investments Management Ltd
Sterling Investments Management Ltd
0.21782%
Braterman (Marc)
Braterman (Marc)

Zoono Group Beneficial Ownership Filings (SEC 13D/G)

Free Float
43.8%
Float Shares
-
Shares Outstanding
-

Zoono Group Executives and Management Board

5 members · avg. age 61 · 20 % women

PH

Mr. Paul Hyslop (65)

Managing Director, Executive Director · since 2017

300,000.00 NZD

Management

PR

Mr. Paul Ravlich

Chief Financial Officer

273,798.00 NZD
LM

Mr. Lewis Mackinnon

Group Chief Operating Officer

183,069.00 NZD

Board of Directors

EH

Ms. Elissa Hansen (50)

Company Secretary, Independent Non-Executive Director

83,732.00 NZD
DC

Mr. Don Clarke (69)

Independent Non-Executive Director

83,732.00 NZD

Zoono Group Supply Chain

Zoono Group Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
7 companies
#NameTrend
1
Alibaba Group Holding
Supplier·CN
-0.37
0.29
-0.10
0.54
0.91
0.65
#NameTrend
1
Bank of America
Supplier·Customer·Banks·US
0.80
0.48
0.13
0.68
-0.05
-0.86
2
Apiam Animal Health
Supplier·Customer·Health Care Providers & Services·AU
-0.15
-0.10
0.32
0.65
0.71
-0.83
3
Bunzl
Customer·Trading Companies & Distributors·GB
0.55
0.54
0.49
-0.37
-0.68
-0.60
4
Citigroup
Supplier·Customer·Banks·US
-0.32
-0.07
0
0.53
0.72
-0.55
5
Cathay Pacific Airways
Customer·Airlines·HK
-0.18
0
0.22
-0.73
-0.53
-0.47

Frequently asked questions about Zoono Group

The business model of Zoono Group Ltd revolves around the development, manufacture, and distribution of a range of antimicrobial solutions. Zoono Group focuses on creating and marketing innovative long-lasting disinfectant products for various applications, including commercial, industrial, and personal use. Their scientifically advanced formulations provide a protective barrier against harmful microbes, delivering extended germ protection. Zoono's products have gained recognition for their effectiveness, durability, and environmentally friendly features. As a leading company in the antimicrobial industry, Zoono Group Ltd continually strives to enhance their product portfolio and expand their global presence.

Zoono Group Ltd is primarily active in the industries of biotechnology, consumer goods, and healthcare.

The main competitors of Zoono Group Ltd in the market include companies such as Microban International, Clorox Company, Reckitt Benckiser Group plc, and 3M Company.

Zoono Group Ltd is a leading company that specializes in the development and production of long-lasting antimicrobial solutions. Established in New Zealand, the company was founded in 2008 and has since expanded its operations globally. Zoono's innovative technology utilizes a unique bonding process that forms a protective barrier capable of eliminating a wide range of bacteria, viruses, and fungi. With a strong commitment to research and development, Zoono has continuously evolved its product offerings, including hand sanitizers, surface sprays, and other disinfecting solutions. Today, Zoono Group Ltd is recognized as a trusted provider of safe and effective antimicrobial protection worldwide.

Zoono Group Ltd, a leading company in the antimicrobial industry, has achieved several significant milestones. Firstly, Zoono gained global recognition for its innovative and highly effective antimicrobial technology, which provides long-lasting protection against a wide range of pathogens. Additionally, the company successfully expanded its product range, catering to various industries including healthcare, consumer, and industrial sectors. Zoono Group Ltd also established strong partnerships with renowned organizations worldwide, enhancing its market presence and distribution capabilities. Furthermore, the company's shares have been listed on prestigious stock exchanges such as the Australian Securities Exchange (ASX) and the London Stock Exchange (LSE), providing investors with increased opportunities. Overall, Zoono Group Ltd has consistently demonstrated its commitment to pioneering antimicrobial solutions and achieving remarkable business growth.

Zoono Group Ltd is primarily present in several countries and regions worldwide. These include Australia, New Zealand, the United Kingdom, Europe, the United States, Canada, Asia, and the Middle East.

Zoono Group Ltd represents a core set of values and a strong corporate philosophy. As a company, Zoono is committed to innovation, transparency, and sustainability. It values continuous improvement and strives to deliver high-quality products and services to its customers. Zoono Group Ltd believes in building strong relationships with stakeholders, including employees, customers, and partners, based on trust and mutual respect. The company's philosophy revolves around responsible business practices, ethical decision-making, and fostering a positive and inclusive work environment. Zoono Group Ltd aims to make a positive impact on society by providing effective and safe antimicrobial solutions.

Converted at the current exchange rate, the Zoono Group share trades at 0.03 EUR (0.06 NZD).

The Zoono Group share (ZNO.AX) is listed on 2 stock exchanges, including: ASX (ZNO.AX).

The company Zoono Group Ltd is a specialist in antimicrobial technologies and offers products and services in various areas. The company is based in New Zealand and operates globally. Zoono's core business offers various antimicrobial solutions based on quaternary ammonium compounds and silver ions. These technologies effectively fight bacteria, viruses, and fungi, reducing the risk of infections. Zoono's business model involves developing, manufacturing, and distributing these technologies. One of Zoono's crucial sectors is the production of products for use in medicine. This includes antiseptic solutions for skin and hand disinfection, as well as wound disinfectants. These products are particularly crucial in hospitals and other medical facilities, where the spread of infections is a significant problem. Another important area in which Zoono operates is the food industry. This includes antimicrobial coatings for packaging and surfaces in food facilities to prevent the growth of bacteria and mold and extend the shelf life of food. Zoono also offers solutions for air and surface disinfection. Zoono's technologies can be used in ventilation systems, air conditioning, and rooms to reduce the spread of bacteria and viruses, thereby minimizing the risk of infection. Furthermore, Zoono offers products for personal use. This includes deodorants, mouthwashes, and hand sanitizers. These products are also intended for use by the general public and aim to reduce the overall risk of infection in society. Recently, the company has also begun to bring its antimicrobial technologies into the field of animal care. This includes antimicrobial dog protection products and products for disinfecting animal shelters and veterinary clinics. In summary, Zoono's business model involves developing, manufacturing, and distributing antimicrobial technologies. The company operates in various areas and sectors, including medicine, the food industry, air and surface disinfection, personal use, and animal care. By providing these products and services, Zoono helps reduce the risk of infection and improve the health and safety of humans and animals.

The revenue cannot currently be calculated for Zoono Group.

The profit cannot currently be calculated for Zoono Group.

The P/E ratio cannot be calculated for Zoono Group at the moment.

The P/S cannot be calculated for Zoono Group currently.

The Eulerpool Quality Score for Zoono Group is 2/10.

The ISIN of Zoono Group is AU000000ZNO4. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Zoono Group is A2PZCA. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Zoono Group is ZNO.AX. The ticker symbol is used to trade Zoono Group shares on the stock exchange.

The current dividend yield of Zoono Group is 51.25 %.

Zoono Group paid dividends every year for the past 0 years.

Zoono Group is assigned to the 'Commodities' sector.

To receive the latest dividend of Zoono Group from amounting to 0.03 NZD, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

The dividends of Zoono Group are distributed in NZD.

All fundamentals and in-depth analysis of Zoono Group

Our stock analysis for Zoono Group stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Zoono Group. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Zoono Group Stock
Zoono Group Revenue→
Zoono Group Stock
Zoono Group Net Income→
Zoono Group Stock
Zoono Group P/E→
Zoono Group Stock
Zoono Group P/S→
Zoono Group Stock
Zoono Group EBIT→
Zoono Group Stock
Zoono Group Dividend→
Zoono Group Stock
Zoono Group Directors Dealings→
Zoono Group Stock
Zoono Group Stocks→
Zoono Group Stock
Zoono Group Market capitalization→
Zoono Group Stock
Zoono Group Debt→
Zoono Group Stock
Zoono Group Liabilities→
Zoono Group Stock
Zoono Group Equity→
Zoono Group Stock
Zoono Group AAQS→
Zoono Group Stock
Zoono Group Employees→
Zoono Group Stock
Zoono Group ROE→
Zoono Group Stock
Zoono Group ROA→
Zoono Group Stock
Zoono Group ROCE→
Zoono Group Stock
Zoono Group News→
Zoono Group Stock
Zoono Group Analyst Price Targets→

Commodities Stocks

ZotefoamsZK International Group CoZRP Printing Group CoZittoZuari Agro ChemicalsZinnwald LithiumZuleika GoldZincX ResourcesZYF Lopsking Material Technology CoZinc One Resources1844 ResourcesZinc of Ireland NLAll Stocks A–Z →